ISRCTN02406823
Active, not recruiting
未知
Multicentre randomised phase II feasibility study evaluating neoadjuvant chemoradiotherapy plus surgery with Surgery Alone In LOw Rectal cancer
Morriston Hospital (UK)0 sites3 target enrollmentJune 6, 2013
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Rectal cancer
- Sponsor
- Morriston Hospital (UK)
- Enrollment
- 3
- Status
- Active, not recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
2016 protocol in: https://www.ncbi.nlm.nih.gov/pubmed/27872117
Investigators
Eligibility Criteria
Inclusion Criteria
- •Current inclusion criteria as of 24/02/2014:
- •1\. Age 18 years and older
- •2\. Histologically confirmed rectal adenocarcinoma
- •3\. Radiologically measurable or clinically evaluable disease
- •4\. Low rectal cancer, defined as within 6cm of anal verge on rigid sigmoidoscopy and considered to require abdominoperineal resection (APR) rather than restorative procedure (anterior resection)
- •5\. Potentially resectable local disease by surgery alone with clear CRM (where visible on MRI) or predicted surgical resection margin (where CRM absent in distal tumours) as determined by MRI
- •6\. Clinical disease stage (MRI\+/\- endorectal US):
- •6\.1\. cT3a/b (\<10 mm) disease within 6 cm of anal verge; or for tumours at/below level of puborectalis
- •6\.2\. through full thickness of muscularis propria (cT2\) disease at level of puborectalis
- •7\. Involvement of internal anal sphincter or intersphincteric space without extension into adjacent levator plate,
Exclusion Criteria
- •Current exclusion criteria as of 24/02/2014:
- •1\. Preoperative chemoradiotherapy absolutely indicated, for example MRI\-predicted CRM/MRF involvement (\<1 mm) by primary or nodal disease, or otherwise unresectable disease;
- •2\. cT3c or d (\>10 mm);
- •3\. Adjacent organ involvement at entry (prostate, seminal vesicles, sacrum or coccyx; T4b) requiring multivisceral resection/ pelvic exenteration;
- •4\. For low tumours at level of puborectalis sling: lateral extension of tumour into external anal sphincter or beyond puborectalis sling into levator plate;
- •5\. Extramural vascular invasion on MRI;
- •6\. Early stage rectal cancer (T1, T2 above level of levators) unless node positive;
- •7\. Locally perforated disease (T4a);
- •8\. Fistulating disease (vagina, perianal skin, adjacent hollow organ);
- •9\. Disease extrusion through anus;
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Evaluation of a computer aid for assessing stomach symptomsISRCTN12595588niversity of Durham (UK)530
Completed
Phase 2
Cediranib maleate with or without gefitinib in treating patients with recurrent or progressive glioblastomaISRCTN00549973niversity College London (UK)38
Active, not recruiting
Phase 2
Radiotherapy combined with immunotherapy in metastatic non-small cell lung cancer patientsCancerAdvanced non-small cell lung cancer, stage IVMalignant neoplasm the lung, non-small cell lung cancerISRCTN49817477Maastricht University88
Active, not recruiting
Not Applicable
Scaphoid Waist Internal Fixation for Fractures Trial: A trial evaluating cast versus surgical fixation for fractures of the scaphoid waist in adultsMusculoskeletal trauma of the hand and wristMusculoskeletal DiseasesISRCTN67901257niversity Hospitals of Leicester NHS Trust (UK)439
Completed
Phase 2
stekinumab in adolescents with recent-onset type 1 diabetesType 1 diabetes mellitusNutritional, Metabolic, EndocrineISRCTN14274380Cardiff University88